Main article: Dialysis
2023
Fresenius injects AI into dialysis systems based on data from 0.5m patients
On October 27, 2023, Fresenius Medical Care announced the completion of the first phase of analysis of the global database of patients who need dialysis. This is one step towards introducing artificial intelligence into dialysis systems. Read more here.
A device has been created to delay dialysis treatment for patients with chronic kidney disease
On September 6, 2023, it was reported that a medical device developed by the Israeli company Curespec is able to delay dialysis treatment of patients with stage three and four chronic kidney disease (CKD) for up to 12 months and is already undergoing clinical trials in hospitals and medical centers in several countries of the world. Read more here.
A technology has been developed that is more effective than dialysis in renal failure. It reduces mortality in such patients by 23%
In June 2023, it became known about the creation of a new dialysis technology, which, according to the developers, is more effective than traditional dialysis for kidney failure. It reduces mortality in such patients by 23%. The find was shared by scientists at the University of Utrecht.
A study comparing high-precision hemodialysis and high-dose hemodiafiltration was conducted to find out which method is better. Hemodialysis for June 2023 is the most common form of dialysis used in the treatment of renal failure. Even though it has improved over the years, hemodialysis does a poor job of removing large molecules from the blood. Hemodiafiltration is a later technology that can remove larger molecules, but it is not suitable for all patients due to the fact that its effectiveness requires a higher blood flow rate. Previous studies have failed to conclusively prove that one method is more effective than the other.
According to the CONVINCE consortium, which is conducting the study, 1,360 patients were randomized at 61 centers in eight European countries, of which 683 received high-dose hemodiafiltration and 677 received high-precision hemodialysis three times a week. During a median follow-up of 30 months, all-cause mortality was 21.9% among patients treated with high-precision hemodialysis, compared with 17.3% among patients treated with high-volume hemodiafiltration. This 4.6% difference represents a 23% reduction in the risk of death.
While hemodialysis is the standard treatment in most countries, hemodiafiltration is used less widely in some places, and in places like the United States it is not used at all. Most modern dialysis machines can perform any of these methods, making the transition to hemodiafiltration relatively simple.
According to Professor Peter Blankestein from the Medical Center of the University of Utrecht, he said that the results show clear advantages in terms of survival when using hemodiafiltration compared with hemodialysis for the treatment of renal failure, which is akin to a 23% reduction in all-cause mortality. Blankestein added that this study proves that exposure to various molecules by hemodiafiltration has obvious benefits for patients. Blankestein hopes hemodiafiltration can become a new standard in medicine.
The CONVINCE study was conducted with the exclusive support of the European Commission for Research and Innovation, Horizon 2020, Call H2020-SC1-2016-2017 on the topic SC1-PM-10-2017: Comparing the Effectiveness of Existing Health Interventions in an Adult Population (Grant# 754803[1]
Peritoneal dialysis device released at home
On January 8, 2023, the Israeli company liberDi announced the Digital Dialysis Clinic. The system allows for peritoneal dialysis outside the health facility. Read more here.
2022: Fresenius launches portable peritoneal dialysis system for home
On April 21, 2022, Fresenius Medical Care announced the entry into the market of a portable Versi PD automated peritoneal dialysis system for the home. The platform is equipped with a touch screen and built-in videos with sound instructions to help patients at each stage of system setup at all stages of treatment. The company plans limited adoption of the Versi PD from the summer of 2022, with wider adoption expected in 2023. Read more here
2021: Baxter AK 98 Announcement - Hemodialysis System with Electronic Medical Card Connectivity
In mid-March 2021, Baxter introduced a new generation hemodialysis device - AK 98 with the function of connecting to electronic medical records. This device offers encrypted two-way communication, allowing the system to extract prescriptions directly from the electronic medical record to simplify workflow and data processing. Read more here.
2020: Fresenius unveils new Deleflex solutions for home dialysis
At the end of October 2020, the company Fresenius Medical Care North America (FMCNA) introduced solutions for peritoneal dialysis Deleflex in a new, almost waste-free package made of Biofine material. It is assumed that the first batches of the new solution will be available to some American patients before the end of 2020. More. here
2019: Fresenius unveils hemodialysis device that prevents blood clots
In late October 2019, Fresenius Medical Care introduced a new hemodialysis system that prevents blood clots. The system contains a polymer called Endexo that reduces the risk of blood clotting, thereby reducing the need for anticoagulants such as heparin. Read more here.
2018: Sales of Tablo Portable Dialysis Home Systems Begin
At the end of August 2018, Outlet Medical introduced the portable dialysis system Tablo, which, as the creators suggest, can soon be used not only in the hospital, but also at home. Read more here.
See also
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |